ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature

BACKGROUND: Although anaplastic lymphoma kinase (ALK) fusion genes are generally identified in lung adenocarcinoma patients, they are relatively rare in patients with squamous cell carcinoma (SqCC). Metastatic ALK-rearranged lung adenocarcinoma patients treated with ALK inhibitors demonstrate higher...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Mamesaya, Nobuaki, Nakashima, Kazuhisa, Naito, Tateaki, Nakajima, Takashi, Endo, Masahiro, Takahashi, Toshiaki
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5501098/
https://ncbi.nlm.nih.gov/pubmed/28683775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3468-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky